Hosted on MSN23h
FDA Approves First Generic Liraglutide Injection, Ushering in a New Era for Type 2 Diabetes Treatment
The fight against type 2 diabetes just reached a groundbreaking milestone. Last week, the U.S. Food and Drug Administration ...
T-Net23h
Lexaria Bioscience Engages Contract Research Organization for Human Pilot Study Evaluating Liraglutide Processed with DehydraTECH
Liraglutide is currently sold only in an injectable form under the brand names Saxenda® and Victoza®, both manufactured by ...